Bibliografia UJ CM

1/4
Nish Chaturvedi, Massimo Porta, Ronald Klein, Trevor Orchard, John Fuller, Hans Henrik Parving, Rudy Bilous, Anne Katrin Sjolie, DIRECT Programme Study Group.
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes : randomised, placebo-controlled trials.
Lancet
2008 : Vol. 372, nr 9647, s. 1394-1402, il., bibliogr. 34 poz., summ.
p-ISSN: 0140-6736
AZ
ORG
AIF
IF: 28.409
2/4
Anne Katrin Sjolie, Ronald Klein, Massimo Porta, Trevor Orchard, John Fuller, Hans Henrik Parving, Rudy Bilous, Nish Chaturvedi, DIRECT Programme Study Group.
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2) : a randomised placebo-controlled trial.
Lancet
2008 : Vol. 372, nr 9647, s. 1385-1393, il., bibliogr. 48 poz., summ.
p-ISSN: 0140-6736
AZ
ORG
AIF
IF: 28.409
3/4
Sabita S. Soedamah-Muthu, Nish Chaturvedi, Daniel R. Witte, Lynda K. Stevens, Massimo Porta, John Fuller, EURODIAB Prospective Complications Group.
Relationship between risk factors and mortality in type 1 diabetic patients in Europe : the EURODIAB Prospective Complications Study (PCS).
Diabetes Care
2008 : Vol. 31, nr 7, s. 1360-1366, bibliogr. 26 poz.
p-ISSN: 0149-5992
AZ
ORG
AIF
IF: 7.349
4/4
Nish Chaturvedi, Anne-Katrin Sjolie, Massimo Porta, Steven J. Aldington, John H. Fuller, Marco Songini, Eva M. Kohner, PCS Group The EURODIAB.
Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes.
Diabetes Care
2001 : Vol. 24, nr 2, s. 284-289, il., bibliogr. 45 poz.
AZ
ORG
AIF
IF: 5.404
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ